Federal contract award

75F40123C00187

THIS IS A FIRM FIXED PRICE CONTRACT FOR BRATS 2023 DATA CENTRIC CHALLENGE

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeFDA OFFICE OF ACQ GRANT SVCS
NAICS541720 — Research and Development in the Social Sciences and Humanities
PSCB529 — Scientific Data Studies
Parent award / vehicleNot reported
Set-asideNO SET ASIDE USED.
Pricing typeFIRM FIXED PRICE
Obligations$107.1K
Current contract value$107.1K
Potential contract value / ceiling$107.1K
Start dateSep 18, 2023
Current end dateFeb 21, 2025
Potential end dateSep 19, 2025
Latest award activityJan 14, 2026
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 4 of 4 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Jan 14, 2026P00003$-60.2KSETTLEMENT FOR THE PRIOR MODIFICATION OF TERMINATION FOR CONVENIENCE OF THE GOVERNMENT
Feb 21, 2025P00002$0THIS FULL TERMINATION WAS NOT DUE TO AN EXECUTIVE ORDER, RATHER FROM A LACK OF AVAILABLE SUBJECTS WITH CERTAIN CONDITIONS. THIS IS A FIRM FIXED PRICE CONTRACT FOR BRATS 2023 DATA CENTRIC CHALLENGE
Sep 12, 2024P00001$0THIS IS A FIRM FIXED PRICE CONTRACT FOR BRATS 2023 DATA CENTRIC CHALLENGE
Sep 18, 20230$167.3KTHIS IS A FIRM FIXED PRICE CONTRACT FOR BRATS 2023 DATA CENTRIC CHALLENGE

Buyer contacts from matching notices

Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.

ContactRolePublished contact methodsEvidenceSource date
Ian WeissContactIan.Weiss@fda.hhs.gov
(301) 796-5728
SourceMay 18, 2023
Ravi Chandan PalaniandyContactRaviChandan.Palaniandy@fda.hhs.gov
301-796-4378
SourceMay 18, 2023
Ian WeissContactIan.Weiss@fda.hhs.gov
(301) 796-5728
SourceJan 17, 2023
Ravi Chandan PalaniandyContactRaviChandan.Palaniandy@fda.hhs.gov
301-796-4378
SourceJan 17, 2023
Ian WeissContactIan.Weiss@fda.hhs.gov
(301) 796-5728
SourceJan 9, 2023
Ravi Chandan PalaniandyContactRaviChandan.Palaniandy@fda.hhs.gov
301-796-4378
SourceJan 9, 2023
Ian WeissContactIan.Weiss@fda.hhs.gov
(301) 796-5728
SourceJan 9, 2023
Ravi Chandan PalaniandyContactRaviChandan.Palaniandy@fda.hhs.gov
301-796-4378
SourceJan 9, 2023
Ian WeissContactIan.Weiss@fda.hhs.gov
(301) 796-5728
SourceJan 4, 2023
Ravi Chandan PalaniandyContactRaviChandan.Palaniandy@fda.hhs.gov
301-796-4378
SourceJan 4, 2023
Ian WeissContactIan.Weiss@fda.hhs.gov
(301) 796-5728
SourceJan 4, 2023
Ravi Chandan PalaniandyContactRaviChandan.Palaniandy@fda.hhs.gov
301-796-4378
SourceJan 4, 2023
Ian WeissContactIan.Weiss@fda.hhs.gov
(301) 796-5728
SourceJan 3, 2023
Ravi Chandan PalaniandyContactRaviChandan.Palaniandy@fda.hhs.gov
301-796-4378
SourceJan 3, 2023
Ian WeissContactIan.Weiss@fda.hhs.gov
(301) 796-5728
SourceNov 17, 2022
Ravi Chandan PalaniandyContactRaviChandan.Palaniandy@fda.hhs.gov
301-796-4378
SourceNov 17, 2022
Ian WeissContactIan.Weiss@fda.hhs.gov
(301) 796-5728
SourceNov 14, 2022
Ravi Chandan PalaniandyContactRaviChandan.Palaniandy@fda.hhs.gov
301-796-4378
SourceNov 14, 2022

Research next steps

  1. Verify whether remaining options may extend performance beyond the current end date.
  2. Check the stated set-aside against the solicitation and current certifications.
  3. Review the award scope and buyer evidence before making a bid/no-bid decision.